Hippocampal estrogen receptor-alpha splice variant TADDI in the human brain in aging and Alzheimer's disease

Neuroendocrinology

Volumn 89, Issue 2, 2009, Pages 187-199

  Ishunina, T A ^a,b   Swaab, D F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b KURSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Aging; Alzheimer's disease; Estrogen receptor splice variants; Human brain; Hypothalamus; Menopause; Nucleus basalis of Meynert

Indexed keywords

BRAIN PROTEIN; ESTROGEN RECEPTOR ALPHA; TADD 1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CEREBELLUM; CONTROLLED STUDY; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; GENETIC VARIABILITY; GRAY MATTER; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; IMMUNOREACTIVITY; MALE; MAMMILLARY BODY; MEDULLA OBLONGATA; MEYNERT BASAL NUCLEUS; PONS ANGLE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR SENSITIVITY; RNA SPLICING; SUPRAOPTIC NUCLEUS; TISSUE SECTION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ALTERNATIVE SPLICING; ALZHEIMER DISEASE; BRAIN; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; POSTMENOPAUSE; PROTEIN ISOFORMS; RNA, MESSENGER; SEX CHARACTERISTICS;

EID: 61749089587     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000158573     Document Type: Article

References (21)

1. Naftolin F, Malaspina D: Estrogen, estrogen treatment and the post-reproductive woman's brain. Maturitas 2007;57:23-26.
2. Brinton RD: Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann NY Acad Sci 2005;1052:57-74.
3. Henderson VW: Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience 2006;138:1031-1039.
4. Genazzani AR, Pluchino N, Luisi S, Luisi M: Estrogen, cognition and female aging. Hum Reprod Update 2007;13:175-187.
5. Mulnard RA: Methodological issues in estrogen treatment trials for Alzheimer's disease. Ann NY Acad Sci 2005;1052:173-181.
6. Ishunina TA, Swaab DF: Age-dependent ERα MB1 splice variant expression in discrete areas of the human brain. Neurobiol Aging 2008;29:1177-1189.
7. Ishunina TA, Fischer DF, Swaab DF: Estrogen receptor α and its splice variants in the hippocampus in aging and Alzheimer's disease. Neurobiol Aging 2007;28:1670-1681.
8. Schultz JR, Loven MA, Melvin VM, Edwards DP, Nardulli AM: Differential modulation of DNA conformation by estrogen receptors α and β. J Biol Chem 2002;277:8702-8707.
9. Picard D, Kumar V, Chambon P, Yamamoto KR: Signal transduction by steroid hormones: nuclear localization is differentially regulated in estrogen and glucocorticoid receptors. Cell Regul 1990;1:291-299.
10. Tcherepanova I, Puigserver P, Norris JD, Spiegelman BM, McDonnell DP: Modulation of estrogen receptor-α transcriptional activity by the coactivator PGC-1. J Biol Chem 2000;275:16302-16308.
11. Teyssier C, Belguise K, Galtier F, Chalbos D: Characterization of the physical interaction between estrogen receptor α and JUN proteins. J Biol Chem 2001;276:36361-36369.
12. van de Nes JA, Kamphorst W, Ravid R, Swaab DF: Comparison of beta-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independently. Acta Neuropathol 1998;96:129-138.
13. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
14. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997;25:3389-3402.
15. Schäffer AA, Aravind L, Madden TL, Shavirin S, Spouge JL, Wolf YI, Koonin EV, Altschul SF: Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements. Nucleic Acids Res 2001;29:2994-3005.
16. Garcia-Ovejero D, Veiga S, Garcia-Segura LM, Doncarlos LL: Glial expression of estrogen and androgen receptors after rat brain injury. J Comp Neurol 2002;450:256-271.
17. Garcia-Segura LM, Melcangi RC: Steroids and glial cell function. Glia 2006;54:485-498.
18. Swaab DF: The human hypothalamus: basic and clinical aspects. I. Nuclei of the human hypothalamus; in Aminoff MJ, Boller F, Swaab DF (eds): Handbook of Clinical Neurology. Amsterdam, Elsevier, 2003, vol 79, 3rd series, vol 1, p 502.
19. Swaab DF: The human hypothalamus: basic and clinical aspects. II. Neuropathology of the human hypothalamus and adjacent structures; in Aminoff MJ, Boller F, Swaab DF (eds): Handbook of Clinical Neurology. Amsterdam, Elsevier, 2004, vol 80, 3rd series, vol 2, p 632.
20. Ishunina TA, van Beurden D, van der Meulen G, Unmehopa UA, Hol EM, Huitinga I, Swaab DF: Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease. Neurobiol Aging 2005;26:173-194.
21. Weiser MJ, Foradori CD, Handa RJ: Estrogen receptor beta in the brain: from form to function. Brain Res Rev 2008;57:309-320.